Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Blood|January 7, 1998
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantationA Freedman, D Neuberg, P Mauch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndromeE D Jacobsen, H T Kim, V T Ho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remissionA S Freedman, D Neuberg, J G Gribben, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignanciesJ W Friedberg, D Neuberg, J G Gribben, et al.Leukemia|September 8, 2012
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcomeJ R Brown, H T Kim, P Armand, et al.Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.Bone Marrow Transplantation|October 27, 2004
Routine screening for psychosocial distress following hematopoietic stem cell transplantationS J Lee, F R Loberiza, J H Antin, et al.Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.Pageof 6